Mirae Asset Global Investments Co., Ltd. Acadia Pharmaceuticals Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,999 shares of ACAD stock, worth $88,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,999

Previous 4,933 21.61%

Holding current value

$88,725

Previous $80,000 15.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$15.14 - $19.14 $16,139 - $20,403	1,066 Added 21.61%	5,999 $92,000
Q2 2024 Jul 30, 2024	SELL	$14.62 - $18.42 $1.05 Million - $1.32 Million	-71,859 Reduced 93.58%	4,933 $80,000
Q1 2024 May 01, 2024	SELL	$17.79 - $30.86 $159,896 - $277,369	-8,988 Reduced 10.48%	76,792 $1.42 Million
Q4 2023 Jan 24, 2024	BUY	$20.78 - $31.77 $92,304 - $141,122	4,442 Added 5.46%	85,780 $2.69 Million
Q3 2023 Oct 26, 2023	BUY	$20.84 - $33.47 $135,855 - $218,190	6,519 Added 8.71%	81,338 $1.7 Million
Q2 2023 Aug 10, 2023	SELL	$17.8 - $25.65 $33,001 - $47,555	-1,854 Reduced 2.42%	74,819 $1.79 Million
Q1 2023 May 04, 2023	BUY	$16.32 - $20.92 $259,814 - $333,046	15,920 Added 26.2%	76,673 $1.44 Million
Q4 2022 Feb 09, 2023	BUY	$14.2 - $18.63 $11,984 - $15,723	844 Added 1.41%	60,753 $967,000
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $197,991 - $256,364	14,032 Added 30.59%	59,909 $980,000
Q2 2022 Jul 26, 2022	BUY	$13.01 - $27.22 $441,351 - $923,411	33,924 Added 283.81%	45,877 $646,000
Q1 2022 May 10, 2022	SELL	$20.94 - $27.5 $9,967 - $13,090	-476 Reduced 3.83%	11,953 $289,000
Q4 2021 Feb 08, 2022	BUY	$16.79 - $27.09 $2,333 - $3,765	139 Added 1.13%	12,429 $290,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $27,615 - $43,347	1,750 Added 16.6%	12,290 $204,000
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $204,475 - $289,006	10,540 New	10,540 $258,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $210,618 - $462,905	-8,418 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$41.04 - $56.79 $13,625 - $18,854	332 Added 4.11%	8,418 $450,000
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $29,427 - $46,056	808 Added 11.1%	8,086 $333,000
Q2 2020 Aug 11, 2020	BUY	$39.26 - $52.73 $285,734 - $383,768	7,278 New	7,278 $352,000

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Acadia Pharmaceuticals Inc Transaction History